Changes of L-arginine/nitric Oxide Synthase/no Pathway of Platelets in Pilots

高连如,张宁坤,丁青艾,王志国,罗书海,许如意,陈宇,杨晔,唐朝枢
DOI: https://doi.org/10.3760/cma.j.issn.1007-6239.2007.03.008
2007-01-01
Abstract:Objective The endothelium plays a pivotal role in maintaining homeostasis of the blood vessels.Nitric oxide(NO)is the key endothelium-derived relaxing factor,which is produced from L-arginine(L-Arg)/NO synthase(NOS)/NO pathway.So in this study,we want to observe the changes of L-arginine/NOS/NO pathway of platelets,and investigate endothelial function in order to prevent cardiovascular disease at early stage in pilots.Methods Thirty-six health pilots,17 match health ground personnel(control group)served as the subjects.3H-L-Arg transport,the NO production,and NOS activity in platelets were measured.Results In pilots group,the ability of L-Arg transport in platelets was lower than that in control group;maximum transport velocity(Vmax)lower 15.0%(t=2.764,P=0.008)than that in control group;michaelis comstant(Km)higher 7.4%(t=2.922,P=0.005)than that in control group;the production of NO in plasma and platelets was obviously lower than that in control group;the activity of NOS in platelets increased but had no statistic significance.Conclusion An abnormal function in L-Arg/NOS/NO pathway was found in pilots because of special work environment and condition.The decrease of nitric oxide generation might result from L-Arg transport injury,while the activity of NOS in platelets was little enhanced for hypoxia compensation.The detection of the alteration of endogenous L-Arg/NOS/NO pathway in platelets might act as an indirect method to assess the endothelial dysfunction involving the pathogenesis of cardiovascular disease in pilots at early stage.
What problem does this paper attempt to address?